Blog Posts (6)
May 26, 2009
One of the wealthiest of the Obama administration appointees, Dr. Margaret Hamburg, has to offload her stock pretty quickly–apparently that’s what comes from being married to a very successful hedge fund manager and holding a wide range of health and other medical related stock, says the Wall Street Journal.…
April 2, 2009
As we reported on our blog a few weeks ago, it wouldn’t be long before many medical institutions were jumping on the conflict of interest bandwagon.…
January 26, 2009
The North American Spine Society has announced that researchers must disclose not only that they receive money from medical device makers but also the sum of those consulting fees, reports the Wall Street Journal.…
December 8, 2008
After the Cleveland Clinic announced last week that it would disclose all of its physician’s financial relationships with pharmaceutical companies, other hospitals are following suit as not to be left behind on the ethics bandwagon.…
October 14, 2008
Disclosing financial conflicts of interest to potential research subjects does not effect their willingness to participate in research, found a recent Johns Hopkins, Duke, and Wake Forest University study.…
March 30, 2008
Scott Haig, an orthopedist, writing in Time about the conflicts of interest that surfaced at the recent annual meeting of the American Academy of Orthopaedic Surgeons:
The DOJ’s slap was felt acutely by everyone at the convention.…
April 17, 2014 5:37 pm
Free samples of prescription drugs may seem like a great deal for patients. But even when doctors think they’re doing patients a favor by handing out the freebies, the real beneficiaries are the drug manufacturers, according to new research in the journal JAMA Dermatology.
December 17, 2013 6:00 pm
GlaxoSmithKline will stop paying doctors for promoting its drugs and scrap prescription targets for its marketing staff – a first for an industry battling scandals over its sales practices, and a challenge for its peers to follow suit.
November 8, 2013 1:41 pm
Regulatory policy should be based on rules that are clear, with a process that is transparent, and on decisions that are accountable and reviewable, and that are congruent with other public policy imperatives.
October 15, 2013 2:35 pm
Even though medical students and trainees were interacting with industry less than before, roughly half of all medical students and residents had received some kind of gift from industry.
September 23, 2013 3:51 pm
Seventeen of 18 scientists who wrote a controversial editorial critical of the European Commission’s plan to regulate endocrine-disrupting chemicals have past or current ties to industries.
August 19, 2013 2:13 pm
An unprecedented Oregon Department of Justice investigation has stepped into an ethical minefield with national implications: When should patients know about a doctor’s payments from companies whose products they use, and whose responsibility is it to tell them?
August 12, 2013 6:58 pm
Doctors who get paid by makers of artificial implants for using their product must let patients know about it, according to a first-of-its-kind legal action by the Oregon Department of Justice.
May 28, 2013 1:58 pm
NIH-funded awards are subject to a prohibition on using federal funds for lobbying activities (the actual language can be viewed here and here).
May 23, 2013 2:26 pm
A rural Oregon family medicine group is an example for other community physicians seeking to wean themselves from pharmaceutical industry influence.
April 30, 2013 12:39 pm
Twice this past week, the US Department of Justice filed lawsuits alleging Novartis paid kickbacks to boost prescriptions and caused federal healthcare programs to pay for medicines based on false claims.
View More News Items